These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


482 related items for PubMed ID: 7662691

  • 21. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg.
    Beksinska ME, Rees VH, Nkonyane T, McIntyre JA.
    Br J Fam Plann; 1998 Apr; 24(1):21-3. PubMed ID: 9719703
    [Abstract] [Full Text] [Related]

  • 25. One-month injectables are popular choice in Mexico.
    Netw Res Triangle Park N C; 1984 Apr; 5(3):4-5. PubMed ID: 12279798
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The future for injectable contraceptives.
    Rutter T.
    Afr Health; 1993 Mar; 15(3):18-9. PubMed ID: 12344840
    [Abstract] [Full Text] [Related]

  • 29. Characteristics of contraceptive acceptors in Luanda, Angola.
    Carvalho A, Laudari C, Marini M, Faundes A.
    Afr J Fertil Sexual Reprod Heal; 1996 Dec; 1(2):109-14. PubMed ID: 12321195
    [Abstract] [Full Text] [Related]

  • 30. Survey report: Senegal.
    Kent MM.
    Popul Today; 1988 Feb; 16(2):5. PubMed ID: 12341736
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z, Biro FM, Kollar LM, Rauh JL.
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [Abstract] [Full Text] [Related]

  • 34. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA, El-genedi MM, Toppozada HK, El-abd M, Loutfi I.
    Dirasat Sukkaniyah; 1984 Aug; 11(69):27-39. PubMed ID: 12179796
    [Abstract] [Full Text] [Related]

  • 35. Reproductive health in adolescence.
    Friedman HL.
    World Health Stat Q; 1994 Aug; 47(1):31-5. PubMed ID: 8085368
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects.
    Basnayake S, Thapa S.
    Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.